The overall market of primary sclerosing cholangitis (PSC) is expected to boost due to the expected launch of emerging therapy in the forecasted period (2023–2032). LAS VEGAS, Oct. 31, 2023 /PRNewswire/ — DelveInsight’s Primary Sclerosing Cholangitis Market Insights report includes a…